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Abstract
Aging has a striking impact on the heart and the vascular system, particularly on the large elastic arteries (i.e.,
aorta), resulting in a multitude of changes at different structural and functional levels. As result, medial
degeneration (MD) occurs. A characteristic example of MD is sporadic thoracic aortic aneurysm (S-TAA),
whose patho-physiological mechanisms remain unclear. In this study, typical MD morphological phenotypes
were researched in S-TAA cases and control aorta specimens by histopathological and immunohistochemical
analyses. Three phenotypes (I, II, and III) were detected, but mainly the phenotype III was observed. Elevated
cystic MD, plurifocal medial apoptosis, and increased metalloproteinase-9 amount characterize it. In addition,
it was significantly correlated with the severity of elastic fragmentation, hypertension, and smoking, and
particularly with advancing age. Thus, phenotype III might represent the typical MD phenotype associated with
S-TAA in old people that have a major risk of aorta rupture and dissection independently on aneurysm
diameter. This might permit the assumption that phenotype III with its typical histological abnormalities is an
optimal biomarker of rupture and/or dissection in aged individuals and is useful both for applying different
surgical approaches and providing appropriate surgical indications.
Introduction
Aging has a striking impact on heart and vascularsystem, particularly on the large elastic arteries (i.e.,
aorta), determining a multitude of changes at different
structural and functional levels.1–3 As result, medial de-
generation (MD) occurs.4 At the macroscopic level, this
pathological entity induces weakening of the aorta wall and
a progressive stiffening.4,5 At the microscopic level, MD is
characterized by endothelial dysfunction, increased oxida-
tive stress, inflammatory reaction, inflammatory cell infil-
tration in the aortic wall, and apoptosis of vascular smooth
muscle cells (VSMCs), followed by degeneration of aortic
media, elastin fracture, and degradation.4,5 In turn, this re-
sults in aortic dilatation and aneurysm, and an increased risk
of the onset of complications, i.e., aortic dissection and
rupture.4 A characteristic model of MD is sporadic thoracic
aortic aneurysm (S-TAA).4 This is becoming a serious
health risk because of growing enhancement of underlying
diseases, i.e., hypertension and aging, in Western popula-
tions.6–10 The aged population seems to experience a in-
creased incidence of S-TAA with advancing of years, as
recently reported by epidemiological studies performed in
geographic regions with stable populations with little out- or
in-migration, such as in Minnesota and Sweden.9,10 Hy-
pertension is a widely prevalent and important risk factor for
cardiovascular diseases, including S-TAA.6 On the other
hand, new guidelines have emphasized hypertension as the
commonest cause of preventable death and as being sig-
nificantly increased in aged population of developed coun-
tries.6
In contrast to the extensive study of syndromic and fa-
milial TAAs, the elucidation on the genetic, molecular, and
cellular mechanisms of sporadic TAA forms has recently
begun.4 On the basis of these observations, the eventual
presence of typical MD morphological phenotypes was
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studied in aorta sporadic TAA samples through histopath-
ological and immunohistochemical analyses. Our major goal
was to identify one phenotype associated mainly with the
risk of aorta rupture and dissection in old people.
Materials and Methods
Aorta specimens from 100 S-TAA patients (97 men and
13 women, whose median age was 62.95 – 11.44 years) and
30 control individuals (20 men and 10 women, mean age
62.9 – 11.57) died of causes unrelated to aortic disease and
no sepsis, confirmed by autopsy, were collected. To perform
histopathological and immunohistochemical analyses, pa-
tient and control aortas were fixed in 10% neutral buffered
formalin for 24 hr, and then processed for routine paraffin
embedding. For examinations by microscopy, multiple his-
tological sections from each sample were prepared and
stained with Hematoxylin & Eosin, Weigert–van Gieson,
and Alcian–Periodic Acid Schiff (PAS). TUNEL (termi-
nal deoxynucleotidyl transferase-mediated dUTP nick end-
labeling) testing and immuno-histochemical assessment for
the evaluation of metalloproteinase-9 (MMP-9) levels and
medial apoptosis were also performed, using procedures
described in Supplementary Data (Supplementary Data are
available at www.liebertonline.com/rej/).
The aortic wall was mainly evaluated for following his-
tological features: (1) Fibrosis (defined as an increase in in-
terstitial collagen); (2) medio-necrosis (defined as a focal
loss of smooth muscle cell nuclei in the media); (3) cystic
medial necrosis (defined as mucoid material accumulation);
(4) focal or medial plurifocal apoptosis; (5) elastic frag-
mentation (defined as focal fragmentation of elastic lamellae
in the media); (6) amounts of MMP-9 (seeSF1c Figs. S1 andSF2c S2).
Histo-pathological abnormalities of aortic wall were
graded and defined according to the definitions and grading
systems used by Matthias Bechtel and colleagues11 and also
described in our recent studies (see Figs. S1 and S2). They
were defined as follows. Cystic medial change: Grade I,
minute cystic cavities holding a basophilic ground substance
that occupy the total width of one lamellar unit; grade II,
cystic cavities holding a basophilic ground substance that
occupy the total width of two or more contiguous lamellar
units; and grade III, large cystic cavities, holding a baso-
philic ground substance, that occupy the total width of aortic
media (Fig. S1). Elastic fragmentation: Grade I, up to five
foci of elastic fibers interruption in two-four neighboring
lamellar units in one microscopic field of 100 ·magnifica-
tion; grade II, more than five foci of elastic fibers inter-
ruption in two-four neighboring lamellar units; grade III,
elastic fibers interruptions occupy the total width of aortic
media with disarray of smooth muscle cells (Fig. S1). Fi-
brosis: Grade I, an increase of collagen fibers in an area less
than one-third of the total medial thickness; grade II, an
increase of collagen fibers occupying between one-third and
two-thirds of the medial thickness; grade III, an increase of
collagen fibers that occupy more than two-thirds of the
medial thickness (Fig. S1). Medial necrosis: Grade I, focal
loss of smooth muscle cells nuclei in an area less than one-
third the thickness of the media; grade II, focal loss of
smooth muscle cells nuclei that occupy between one-third
and two-thirds the medial thickness; grade III, focal loss of
smooth muscle cells nuclei that occupy more than two-thirds
the medial thickness (Fig. S1). Atherosclerotic aneurysms:
We have defined atherosclerotic aneurysms as those that
showed macroscopic intimal calcific plaques or microscopic
intimal fibrotic thickness that is one-third that of the aortic
media thickness.
Statistical analysis
Correlations were assessed using Spearman rank corre-
lation. A p < 0.05 was considered statistically significant.
Results
Interestingly, 73 case aorta tissues were with the typical
MD and without atherosclerotic lesions. In these tissues,
three phenotypes (I, II, and III) were detected having a
different quantitative relationship of cystic MD, fibrosis,
apoptosis, and amount of MMP-9 (see Figs. S1 and S2).
They were described as follows: Phenotype I, cystic medial
degeneration balanced by a substitutive fibrosis, in absence
of medial apoptosis and with a low MMP-9 concentration;
phenotype II, higher cystic medial degeneration than sub-
stitutive fibrosis, with focal medial apoptosis, and with
mainly a modest MMP-9 amount; phenotype III, elevated
cystic medial degeneration, without substitutive fibrosis,
with plurifocal medial apoptosis, and with an elevated
MMP-9 concentration.
Among these, phenotype III was mainly (63 vs. 73) ob-
served in case aortas. It showed elevated cystic MD, plur-
ifocal medial apoptosis, and increased MMP-9 amount (see
b F1Fig. 1A,B). In addition, phenotype III was significantly cor-
related with the severity of elastic fragmentation, hyperten-
sion, smoking, and particularly with advancing age (r= 0.497,
p= 0.0001; r= 0.267, p= 0.03; r= 0.342, p= 0.006; r= 0.567,
p= 0.0001, respectively; by non-parametrical Spearman cor-
relation test; data not shown). In contrast, no correlation was
observed with aorta diameter (data not shown). Thus, pheno-
type III might represent the typical MD phenotype associated
with major risk of aorta rupture and dissection independently
on aneurysm diameter.
Discussion
Aortic disease is currently a large health concern because
it is common particularly in advancing age and can lead to
fatal outcomes.12 A variety of conditions affect the aorta
with progressing years; the most common are aneurysm,
dissection, occlusion owing to atherosclerosis, and general
stiffening.12 These conditions are characterized by micro-
structural changes that frequently are the result of vascular
aging.1–3 Indeed, aging determines the loss of molecular
fidelity at cellular, tissue, and organ levels, including the
heart and vascular system, followed by a progressive en-
tropy, which renders patients more easily vulnerable to
internal and external stressors, frailty, disability, and
disease.13 In the thoracic aorta, age-related modifications
give rise to a pathological entity, MD, having catalyst and
accelerator effects for the onset of S-TAA.4 Thus, S-TAA
risk increases with biological aging. Little has been known
until now about the histopathological MD-related pheno-
types associated with a major risk for S-TAA and its com-
plications, especially in old people.4,14–16 This led us to
perform histopathological studies to identify phenotypes of
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S-TAA, which, more than others, evolve into dissection
or rupture.17,18
In a previous study, we detected a morphological identity
of medial lesions that might be assumed as precursor and
consequently as optimal biomarker of type A dissection
(TAD), independently of aneurysm diameter or valvular
disorder.17 On the other hand, we observed that the severity
of aortic media degeneration in TAD cases is not related to
the diameter of the aneurysm.17 Other research groups fre-
quently found the onset of TAD in patients with a normal
aortic diameter.17,18 These promising findings encouraged us
to find phenotypes associated with the risk of aorta rupture
and dissection in aged S-TAA individuals. Thus, in the
present study, histopathological and immunohistochemical
analyses were assessed in aorta specimens from 100 S-TAA
patients with median age of 62.95 – 11.44 years and age-
and gender-matched controls. Interestingly, we observed
that a large number of aorta samples showed a morpho-
logical identity, defined as phenotype III and characterized
by elevated cystic MD, plurifocal medial apoptosis, and
increased MMP-9 levels. This phenotype appears to be
significantly correlated with the severity of elastic frag-
mentation. In addition, it shows a relative absence of a repara-
tive fibrosis, and consequently it might mainly predispose the
FIG. 1. (A and B) Aorta wall abnormalities characterizing phenotype III. (A) Elastic fragmentation, medio-necrosis, and
cystic necrosis essentially of grades II and III were found. (B) Focal and plurifocal apoptosis were also found in all tissue
aorta samples from patients versus controls. In addition, low, moderate, and elevated metalloproteinase-9 (MMP-9)
amounts were also observed.
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S-TAA patients to aortic rupture. These data seem to be in
agreement with the emerging literature data suggesting the key
involvement of an up-regulation of metalloproteinase and ap-
optosis correlated with inflammatory age-related processes
and genetic factors in the pathophysiology of S-TAA.18 On the
other hand, we recently suggested that inflammation produc-
ing MMPs, cytokines, and death mediators seem to be the
shared pathological mechanism for TAD. In addition, signifi-
cant associations between single-nucleotide polymorphisms
in inflammatory genes and the TAD risk were also reported in
our study.18
Furthermore, phenotype III seems to be the result of three
major risk factors of S-TAA, including hypertension,
smoking, and advancing age. Indeed, a significant positive
correlation was, observed between phenotype III and these
risk factors. On the other hand, in a recent study we dem-
onstrated that smoking, hypertension, and age were the ex-
clusive risk S-TAA factors significantly associated with the
reduction of the mean leukocyte telomere length.19 Their
association seems plausible with the biological effects that
they mediate on the aortic wall. In contrast, no correlation
was observed with aortic diameter.
Together our results, although obtained from a relatively
large number of individuals, might indicate that phenotype
III, with its typical histological abnormalities, is an optimal
biomarker of rupture and/or dissection in aged individuals
and would be useful both for applying different surgical
approaches and providing appropriate surgical indications.
On the other hand, an increase of S-TAA incidence in the
aged population has been recently observed by epidemio-
logical studies.7,9,10 In addition, this might be useful be-
cause S-TAA is clinically and predominantly a silent
ailment until rupture or dissection occurs and is insidious
in its onset and progression. Furthermore, until now its
diagnosis is also exclusively based on imaging technolo-
gies, and no blood tests exist. Certainly, our findings re-
quire continued research on the genetic, cellular, and
molecular mechanisms involved in the development of this
phenotype. It and combined efforts might lead to further
elucidation about the role of S-TAA phenotype III, espe-
cially in old people.
A major advance would be to be translate these findings
into individualized and effective pharmacological treat-
ments oriented toward molecular and genetic mechanisms,
allowing for tailored medical and surgical approaches to this
very serious condition.20 Accordingly, recently Castellano
and colleagues emphasized that we are ignoring this disease,
which is growing in incidence and characterized by a dif-
ferent location and etiology with respect to abdominal aorta
aneurysm (AAA). These aortic diseases need to be consid-
ered as distinct entities and not hastily grouped together.
Thus, the aortic diameter and therapies used for AAA care
are not suitable for S-TAA, as recently evidenced by
new guidelines for S-TAA.21 Clinical trials for S-TAA are
required before medical therapies, such as b-blockers,
angiotensin-converting enzyme inhibitors, angiotensin re-
ceptor blockers, statins, or macrolide antibiotics, can be
recommended. On the other hand, we have proposed in our
recent studies that a surgical approach for patients with S-
TAA should consider not only the diameter of the aortic
aneurysm portion but also the histological features and the
genetic risk profile.17,18,22
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Supplementary Data
Immunohistochemical assays
Immunohistochemical analyses were performed on 5-lm-
thick paraffin-embedded sections. Deparaffinized sections
were treated for 20min in a microwave oven in 10mM
citrate buffer (pH 6) or Tris/EDTA (pH 9). Sections were
then incubated for 1 hr with specific monoclonal antibodies
(mAbs) against metalloproteinase-9 (MMP-9) (clone 15W2,
NCL-MMP9 439, Novocastra Laboratories Ltd, UK 1:50) or
isotype-matched controls at appropriate dilutions. After
washing in 1 ·Tris-buffered solution (TBS), staining was
performed by biotinylated link antibody and streptovidin
labeled with Peroxidase Kits (Dako, North America, Inc.,
USA) and was detected using 3-amino-9-ethylcarbazole
(AEC) substrate chromogen. After counterstaining of cells
and tissue sections was performed using aqueous Hema-
toxylin (Novocastra Laboratories Ldt, UK).
Inflammatory and immune cells were counted in 10
contiguous high-power fields (magnification, 400· ) under
an Olympus fluorescent microscope (America Inc., Melville,
NY) by two independent observers.
TUNEL testing
We performed terminal deoxynucleotidyl transferase
(TdT)-mediated X-deoxyuridine triphosphate nucleotide (X-
UTP) nick end-labeling (TUNEL) reaction (In Situ Cell Death
Detection Kit, Roche Diagnostics S.p.A, Milano, Italy) on
full-thickness aortic wall paraffin sections (5lm). Tissues
were deparaffined and then permeablized with phosphate-
buffered saline (PBS) 0.1% sodium citrate/0.1% Triton X-100.
Specimens were then incubated with TdT and fluorescein-
labeled dUTP in a humidified atmosphere for 1 hr at 37C.
In situ apoptosis staining was revealed by using an AP con-
verter. DNAstrandbreakswere detected byusing the 5-bromo-
4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (BCIP/
NBT; Dako, Italy) substrate chromogen. Tissues were subse-
quently counterstained with Eosin under light microscopy.
SUPPLEMENTARY FIG. 1. Control aortas and histo-pathological abnormalities in aorta tissues of S-TAA patients.
Normal aorta (a, a1, a2, a3). Cystic medial changes of grade I (b), II (c) and III (d); Elastic fragmentation of grade I (b1), II
(c1) and III (d1). Medial fibrosis of grade I (b2), II (c2) and III (d2). Medial necrosis of grade I (b3), II (c3) and III (d3).
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SUPPLEMENTARY FIG. 2. Medial apoptosis and MMP-9 amounts in tissue samples. In a2 and a3 images of control
aorta wall conditions. In b2 and c2 images of focal and plurifocal medial apoptosis, respectively, in patient tissues. In b3
(low), c3 (moderate) and d3 (elevated) levels of MMP-9 in patient samples.
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